Phio Pharmaceuticals（PHIO.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他88.87%
机构投资者10.38%
个人与内部人士0.75%

主要股东

主要股东最新
股东
Orca Capital GmbH	4.64%	53.87 万	0.00%	+0	2025/12/08
Vanguard Capital Management, LLC	1.14%	13.24 万	0.12%	+1.44 万	2026/06/30
Jane Street Group, LLC	1.03%	11.92 万	--	+11.92 万	2026/03/31
Geode Capital Management, LLC	0.99%	11.46 万	0.28%	-3.27 万	2026/06/30
Robert BittermanPresident, CEO & Chairman	0.44%	5.14 万	0.09%	+1.00 万	2026/06/26
Nomura Investment Management Business Trust	0.43%	5.00 万	0.00%	+0	2026/03/31
Cetera Investment Advisers LLC	0.41%	4.75 万	0.02%	+2,500.00	2026/06/30
Hudson River Trading LLC	0.30%	3.47 万	--	+3.47 万	2026/03/31
Two Sigma Investments, LP	0.28%	3.25 万	0.15%	+1.80 万	2026/03/31
Scientech Research LLC	0.26%	3.00 万	--	+3.00 万	2026/03/31
Northern Trust Global Investments	0.24%	2.78 万	0.03%	+4,010.00	2026/06/30
XTX Markets Limited	0.21%	2.49 万	--	+2.49 万	2026/03/31
Robert FerraraFormer Independent Director	0.13%	1.57 万	0.00%	+0	2025/09/11
Two Sigma Securities, LLC	0.13%	1.52 万	--	+1.52 万	2026/03/31
Citigroup Inc.	0.10%	1.16 万	0.09%	+1.06 万	2026/06/30
CapFinancial Partners, LLC	0.09%	1.00 万	0.00%	+0	2026/06/30
Patricia BradfordIndependent Director	0.07%	8,351.00	0.00%	+0	2026/03/05
Robert InfarinatoFormer Vice President & Chief Financial Officer	0.07%	7,659.00	--	+7,659.00	2026/03/05
Tower Research Capital Europe Limited	0.05%	6,206.00	0.01%	-1,414.00	2026/06/30
UBS Asset Management AG	0.05%	5,387.00	0.19%	-2.16 万	2026/06/30